Morgan Stanley’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.73B | Buy |
47,632,487
+2,686,466
| +6% | +$310M | 0.35% | 43 |
|
|
2025
Q4 | $4.73B | Buy |
44,946,021
+359,486
| +0.8% | +$33.7M | 0.28% | 56 |
|
|
2025
Q3 | $3.74B | Buy |
44,586,535
+385,841
| +0.9% | +$31.8M | 0.23% | 77 |
|
|
2025
Q2 | $3.5B | Buy |
44,200,694
+1,086,242
| +3% | +$86.3M | 0.23% | 78 |
|
|
2025
Q1 | $3.87B | Sell |
43,114,452
-1,069,247
| -2% | -$99.8M | 0.28% | 59 |
|
|
2024
Q4 | $4.4B | Sell |
44,183,699
-208,123
| -0.5% | -$21.5M | 0.31% | 51 |
|
|
2024
Q3 | $5.04B | Buy |
44,391,822
+2,174,461
| +5% | +$258M | 0.37% | 42 |
|
|
2024
Q2 | $5.23B | Buy |
42,217,361
+711,506
| +2% | +$91.7M | 0.4% | 37 |
|
|
2024
Q1 | $5.48B | Sell |
41,505,855
-38,753,795
| -48% | -$4.78B | 0.44% | 35 |
|
|
2023
Q4 | $8.75B | Buy |
80,259,650
+41,664,857
| +108% | +$4.32B | 0.39% | 40 |
|
|
2023
Q3 | $3.97B | Sell |
38,594,793
-572,824
| -1% | -$61.7M | 0.4% | 38 |
|
|
2023
Q2 | $4.52B | Buy |
39,167,617
+122,796
| +0.3% | +$13.9M | 0.45% | 37 |
|
|
2023
Q1 | $4.15B | Sell |
39,044,821
-2,805,260
| -7% | -$303M | 0.45% | 38 |
|
|
2022
Q4 | $4.64B | Buy |
41,850,081
+4,000,816
| +11% | +$409M | 0.53% | 26 |
|
|
2022
Q3 | $3.26B | Sell |
37,849,265
-126,218
| -0.3% | -$11.3M | 0.44% | 39 |
|
|
2022
Q2 | $3.46B | Buy |
37,975,483
+12,483,322
| +49% | +$1.11B | 0.45% | 38 |
|
|
2022
Q1 | $2.09B | Sell |
25,492,161
-3,932,782
| -13% | -$310M | 0.28% | 79 |
|
|
2021
Q4 | $2.26B | Buy |
29,424,943
+3,287,041
| +13% | +$262M | 0.28% | 82 |
|
|
2021
Q3 | $1.96B | Sell |
26,137,902
-151,594
| -0.6% | -$11.5M | 0.26% | 88 |
|
|
2021
Q2 | $2.04B | Buy |
26,289,496
+2,754,130
| +12% | +$205M | 0.27% | 83 |
|
|
2021
Q1 | $1.73B | Sell |
23,535,366
-117,330
| -0.5% | -$8.65M | 0.25% | 92 |
|
|
2020
Q4 | $1.85B | Buy |
23,652,696
+3,376,142
| +17% | +$258M | 0.29% | 79 |
|
|
2020
Q3 | $1.6B | Buy |
20,276,554
+685,051
| +3% | +$53.7M | 0.31% | 77 |
|
|
2020
Q2 | $1.45B | Buy |
19,591,503
+798,661
| +4% | +$60.1M | 0.32% | 76 |
|
|
2020
Q1 | $1.38B | Sell |
18,792,842
-540,037
| -3% | -$42.4M | 0.37% | 62 |
|
|
2019
Q4 | $1.68B | Buy |
19,332,879
+1,517,131
| +9% | +$125M | 0.39% | 45 |
|
|
2019
Q3 | $1.43B | Buy |
17,815,748
+983,645
| +6% | +$78.8M | 0.38% | 49 |
|
|
2019
Q2 | $1.35B | Buy |
16,832,103
+165,586
| +1% | +$12.7M | 0.36% | 55 |
|
|
2019
Q1 | $1.32B | Sell |
16,666,517
-4,334,878
| -21% | -$324M | 0.37% | 54 |
|
|
2018
Q4 | $1.53B | Buy |
21,001,395
+3,639,178
| +21% | +$257M | 0.46% | 33 |
|
|
2018
Q3 | $1.18B | Buy |
17,362,217
+692,903
| +4% | +$44.1M | 0.29% | 72 |
|
|
2018
Q2 | $965M | Buy |
16,669,314
+156,611
| +0.9% | +$8.84M | 0.26% | 80 |
|
|
2018
Q1 | $858M | Buy |
16,512,703
+1,440,794
| +10% | +$77.8M | 0.24% | 86 |
|
|
2017
Q4 | $809M | Sell |
15,071,909
-619,724
| -4% | -$34.4M | 0.22% | 90 |
|
|
2017
Q3 | $959M | Buy |
15,691,633
+338,630
| +2% | +$20.5M | 0.29% | 67 |
|
|
2017
Q2 | $939M | Sell |
15,353,003
-545,141
| -3% | -$33.2M | 0.28% | 70 |
|
|
2017
Q1 | $964M | Sell |
15,898,144
-441,144
| -3% | -$26.8M | 0.3% | 69 |
|
|
2016
Q4 | $918M | Buy |
16,339,288
+2,979,683
| +22% | +$174M | 0.3% | 59 |
|
|
2016
Q3 | $796M | Sell |
13,359,605
-2,122,655
| -14% | -$124M | 0.27% | 70 |
|
|
2016
Q2 | $851M | Buy |
15,482,260
+3,516,614
| +29% | +$187M | 0.31% | 55 |
|
|
2016
Q1 | $604M | Sell |
11,965,646
-1,398,523
| -10% | -$68.5M | 0.23% | 95 |
|
|
2015
Q4 | $674M | Buy |
13,364,169
+890,953
| +7% | +$44.9M | 0.24% | 90 |
|
|
2015
Q3 | $588M | Buy |
12,473,216
+178,747
| +1% | +$9.5M | 0.22% | 100 |
|
|
2015
Q2 | $668M | Buy |
12,294,469
+953,389
| +8% | +$53.5M | 0.23% | 89 |
|
|
2015
Q1 | $622M | Sell |
11,341,080
-2,110,663
| -16% | -$120M | 0.23% | 99 |
|
|
2014
Q4 | $729M | Buy |
13,451,743
+1,774,618
| +15% | +$98.9M | 0.27% | 71 |
|
|
2014
Q3 | $661M | Buy |
11,677,125
+1,150,955
| +11% | +$64.6M | 0.25% | 77 |
|
|
2014
Q2 | $581M | Buy |
10,526,170
+267,251
| +3% | +$14.6M | 0.23% | 84 |
|
|
2014
Q1 | $556M | Buy |
10,258,919
+364,821
| +4% | +$18.9M | 0.23% | 86 |
|
|
2013
Q4 | $473M | Sell |
9,894,098
-38,912
| -0.4% | -$1.78M | 0.2% | 109 |
|
|
2013
Q3 | $451M | Sell |
9,933,010
-78,962
| -0.8% | -$3.61M | 0.21% | 103 |
|
|
2013
Q2 | $444M | Buy |
+10,011,972
| New | +$447M | 0.22% | 99 |
|
Other funds holding MRK
VCM
VPM
Morgan Stanley's MRK Position: Q1 2026 in Review
Morgan Stanley increased its Merck (MRK) stake by 6% in Q1 2026, buying an estimated $310M and bringing the position to 47,632,487 shares worth $5.73B. The position accounts for 0.35% of the portfolio, ranked #43.
Morgan Stanley first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.75B in Q4 2023. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Morgan Stanley held 47,632,487 shares of Merck worth $5.73B as of Q1 2026.
- Morgan Stanley bought 2,686,466 Merck shares in Q1 2026, an estimated $310M.
- Merck made up 0.35% of Morgan Stanley's portfolio in Q1 2026, its #43 holding.
- Morgan Stanley first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
- Morgan Stanley's Merck position peaked at $8.75B in Q4 2023.
- 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.